Eastern Bank’s Vanda Pharmaceuticals VNDA Stock Holding History

Eastern Bank’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.6K	Hold	5,000	–	–	﹤0.01%	761
2026 Q2	$30.6K	Hold	5,000	–	–	﹤0.01%	700
2026 Q1	$34.6K	Hold	5,000	–	–	﹤0.01%	631
2025 Q4	$44.1K	Hold	5,000	–	–	﹤0.01%	596
2025 Q3	$25K	Hold	5,000	–	–	﹤0.01%	682
2025 Q2	$23.6K	Hold	5,000	–	–	﹤0.01%	655
2025 Q1	$23K	Hold	5,000	–	–	﹤0.01%	668
2024 Q4	$24K	Hold	5,000	–	–	﹤0.01%	666
2024 Q3	$23.4K	Buy	+5,000	New	+$26.8K	﹤0.01%	662

Other funds holding VNDA

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Eastern Bank's VNDA Position: Q3 2026 in Review

Eastern Bank held its Vanda Pharmaceuticals (VNDA) position steady in Q3 2026 at 5,000 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Eastern Bank first reported a position in VNDA in Q3 2024 and has held it in 9 quarters since. The position peaked at $44.1K in Q4 2025. 19 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

Eastern Bank held 5,000 shares of Vanda Pharmaceuticals worth $24.6K as of Q3 2026.
Eastern Bank left its Vanda Pharmaceuticals share count unchanged in Q3 2026.
Vanda Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #761 holding.
Eastern Bank first reported a position in Vanda Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
Eastern Bank's Vanda Pharmaceuticals position peaked at $44.1K in Q4 2025.
19 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.